Castill Health Announces Plans for Philippines Digital Healthcare Launch, Supported by Craig Astill and Caason Group 
PDF to PPT Converter From Presentations.AI Turns PDFs Into Editable PowerPoint Slide Decks With AI, Keeping Charts, Tables and Images Intact, as a Free-to-Try Gamma and Beautiful.ai Alternative 
Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
MALVERN, Pa., July 28, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
Travere Therapeutics to Report Second Quarter 2022 Financial Results
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Cellectis to Report Second Quarter 2022 Financial Results
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) — Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
SIGA Technologies to Host Business Update Call on August 4th, 2022 Following Release of Second Quarter 2022 Financial Results
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a…
Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2022 Financial and Operational Results on August 11, 2022
BEDMINSTER, N.J., July 28, 2022 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB),…
Relay Therapeutics to Announce Second Quarter 2022 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage…
Myriad Genetics to Release 2022 Second-Quarter Financial Results on Aug. 4, 2022
SALT LAKE CITY, July 28, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Larimar Therapeutics Announces Presentation at the Upcoming Gordon Research Conference on Neurobiology of Brain Disorders
BALA CYNWYD, Pa., July 28, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…
Vaxart to Host Second Quarter 2022 Business Update and Financial Results Conference Call on August 8
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., July 28, 2022…
Icosavax Announces Results from IVX-411 Drug Product Investigation and Outlines Additional Corporate Milestones
– Antigen component of IVX-411 found to be unstable; issue specific to molecule, with no…
AVEO Oncology to Announce Second Quarter 2022 Financial Results on August 4, 2022
BOSTON, July 28, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical…
Eagle Pharmaceuticals to Host Second Quarter 2022 Financial Results on August 9, 2022
WOODCLIFF LAKE, N.J., July 28, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (“Eagle” or the…
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2022 Financial Results on August 8, 2022
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT…
Revolution Medicines to Report Financial Results for Second Quarter 2022 After Market Close on August 9, 2022
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
Coherus BioSciences to Report Second Quarter 2022 Financial Results on August 4th, 2022
REDWOOD CITY, Calif., July 28, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…
Inventiva Reports 2022 First-Half Financial Information¹
Cash position2 at €87.2 m as of June 30, 2022 Revenues of €0.1 m in…
Umoja Biopharma Presents New Preclinical Data at the 2022 iPSC Manufacturing Summit on Synthetic Receptor Enabled Differentiation, a Novel Approach for the Differentiation and Expansion of Induced Pluripotent Stem Cells to Generate Cytotoxic Innate Lymphocytes
New data demonstrates Umoja’s synthetic receptor enabled differentiation (ShRED™) as a novel platform to differentiate…
Intellabridge Provides Update on Annual Filings and Q1 2022 Interim Financial Statements
Menlo Park, California; Vancouver, British Columbia; and Boulder, Colorado–(Newsfile Corp. – July 28, 2022) –…
CardioComm Solutions Issue Stock Options
Toronto, Ontario–(Newsfile Corp. – July 28, 2022) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or…
Science Publication First to Describe Modifi Bio’s Novel Approach to Fight Cancer Cells with DNA Modification
Yale Spinout Modifi Bio announces seed funding NEW HAVEN, Conn., July 28, 2022 (GLOBE NEWSWIRE)…